Canada signs deal with Novavax to make its COVID-19 vaccine at new Montreal facility New prescription hypnotic for insomnia now available in CanadaFirst marketed orexin receptor antagonist is approved for adults with difficulties in falling asleep and/or maintaining sleep. Nonbenzodiazepine hypnotic, Lunesta (eszopiclone) now marketed in Canada Approved for short-term use in adults with difficulty falling asleep, or nocturnal or early morning awakenings. Canada signs agreements for millions of COVID-19 vaccines Finding your niche: Going to the pharma side Pharmaceutical industry provides professional opportunities + personal perks Medical cannabis and the unmet needs of chronic pain in Canada Suspect COVID-19 in patients presenting with neurological symptoms Neurological manifestations may include impaired consciousness, stroke, ataxia, seizure, taste/smell impairment, vision impairment, nerve pain and skeletal muscle pain GSK and Pfizer merge OTC divisions to become largest company of its kind in the world Under the terms of the transaction, Pfizer holds a 32% interest in the joint venture and GSK a 68% interest. Twinrix hepatitis vaccine often prescribed for travellers in short supply A Canada-wide shortage of the vaccine that protects against both hepatitis A and B could put a bit of a damper on Canadian sun-seekers' travel plans this winter. GSK and Pfizer to merge healthcare divisions It is expected to take three years to merge the businesses across some 100 countries First Previous 7 8 9 10 11 Next Last
